Quironsalud Madrid
Le Dr Jaume Capdevila est un chercheur de premier plan dans le domaine des thérapies ciblées du cancer de la thyroïde, avec plus de 1 100 traitements réalisés au Centro Médico Teknon.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Le Dr Raventos a réalisé plus de 1 100 interventions pour le cancer de la thyroïde au cours de ses 49 ans de carrière et dirige le département de chirurgie mini-invasive du Centro Médico Teknon.
Le Dr Joseba Rebollo Liceaga apporte plus de 30 ans d'expérience en oncologie, se spécialisant dans le cancer de la thyroïde à Quironsalud Torrevieja.
Thyroid cancer treatment in Spain focuses on surgical resection, radioactive iodine therapy, and advanced radiotherapy. JCI-accredited centers in Madrid and Barcelona utilize robotic-assisted thyroidectomy and Proteus One proton-beam technology. These facilities specialize in treating papillary, follicular, and endocrine-specific carcinomas through multidisciplinary oncology teams.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon demonstrate significant depth in endocrine surgery with specialists like Prof. Dr. Jose Maria Raventos. He brings over 45 years of experience from institutions like the Mayo Clinic. This high-volume expertise is a critical quality marker. While many hospitals offer basic thyroidectomy, clinics in Madrid and Barcelona perform over 23,000 annual operations. This volume ensures surgeons maintain the highest technical proficiency for complex cases.
Patient Consensus: Patients emphasize the strict isolation protocol required for radioactive iodine therapy. Many suggest starting the necessary low-iodine diet at least 2 weeks before the procedure begins.
Spain hosts globally recognized centers for thyroid cancer care, primarily in Madrid and Barcelona. Clinica Universidad de Navarra and Centro Medico Teknon lead with advanced endocrine surgery units. These facilities offer comprehensive diagnostics, including PET-CT and fine-needle aspiration, alongside specialized radioactive iodine and proton therapy.
Bookimed Expert Insight: While many seek private care for speed, the high volume at Centro Medico Teknon is a major differentiator. The clinic manages 10,000 patients annually. This volume correlates with higher surgical precision in complex endocrine cases. Choosing centers with dedicated endocrine tumor units often ensures access to intraoperative nerve monitoring.
Patient Consensus: Patients emphasize choosing university hospitals in Madrid or Barcelona for multidisciplinary expertise. Many suggest preparing for post-operative calcium needs and checking if surgery packages include radioiodine therapy.
Discussing thyroid cancer with a specialist in Spain involves evaluating tumor biology, surgical extent, and radiotherapy options. You should ask about your cancer subtype, genetic markers like BRAF, and the staging. Inquire if specialized Proteus One proton therapy or radioiodine is necessary for your specific case.
Bookimed Expert Insight: Spanish centers like Proton Therapy Centre Quironsalud are pioneers in using Proteus One technology. Data shows that specialists here often have international backgrounds, with some trained at Massachusetts General Hospital. When asking about experience, check if your doctor has performed over 900 cases. This level of expertise is common in Madrid's high-volume, JCI-accredited facilities.
Patient Consensus: Patients emphasize asking for written summaries to manage the initial consultation shock. Many suggest bringing a note-taker to track details about hormone dosing and potential private care wait times.
MIVAT is available in Spain primarily at specialized tertiary centers in Madrid and Barcelona. Notable facilities providing this technique include Centro Medico Teknon and Clinica Universidad de Navarra. Leading endocrine surgeons use small incisions under 2 cm to enable faster recovery and superior aesthetic results.
Bookimed Expert Insight: Spanish healthcare data shows a high concentration of advanced endocrine expertise in private JCI-accredited centers. Clinica Universidad de Navarra was Spain first JCI-certified hospital. This specialization often translates to better access to specific techniques like MIVAT compared to general regional hospitals. Patients should confirm if a center offers MIVAT specifically or robotic-assisted thyroidectomy as an alternative.
Patient Consensus: Patients note that MIVAT is often treated as a specialized technique limited to major cities. Many suggest explicitly asking surgeons about their specific training and caseload in video-assisted methods before booking.
Proton therapy is selected for thyroid cancer in Spain when tumors are refractory to radioactive iodine or recur in previously irradiated areas. It is vital for protecting critical neck structures like the spinal cord and esophagus. This method is preferred for pediatric cases to reduce secondary cancer risks.
Bookimed Expert Insight: While many oncology centers in Spain offer comprehensive thyroid care, dedicated proton centers like Proton Therapy Centre Quironsalud utilize Proteus ONE technology. Our data shows these specialized centers often bundle essential 3D CT and MRI diagnostics into treatment packages, which is crucial since precise mapping is the primary reason for choosing protons over conventional radiation in complex neck anatomy.
Patient Consensus: Patients note that proton therapy is rarely a first-line choice but becomes a critical discussion point for recurrent cases or when protecting the heart and lungs is necessary. Many emphasize the importance of seeking second opinions at major centers in Madrid or Barcelona if standard radiation risks are high.